there seems to be some heavy resistance around these level with a lot of potential upside.

its on steriods today trading up

Any comment on this one? Their vaccines seem to generate good profit and growth potential.

It's been low and unpopular for years. I like the stock but unconvinced it is yet time to buy, however good long term hold. The sector will come back into favour and I'm pleased with the new CEO appointment.

I think the low dollar is really affecting earnings, there is a lot of uncertainty with Avandia and the associated legal issues but it has been hammered and is tempting but perhaps whern the dollar bounces back will be the time to buy

Quite agree falco. Then it will be dirt cheap and will get back to the old levels over 22. Incredible to think I sold stock up there years ago, but had held through the Girolami and Sir Richard years - ie. a long time!

Agree with Greyhound, Andrew Witty is way better positioned to capture Asia's growth.

Holding up pretty well. Not bad for income I think.

If you want income buy UK banks now!

Seems like good value to me like I said earlier. Anyone?

And for those who are still concern with Avandia, it is not that bad after all. See:

http://www.reuters.com/article/health-SP/idUSL1214902720071113

It's the pipeline and the dollar effect that is causing the lacklustre performance imo.

Thought GSK has got one of the largest pipeline?

Promising update on Avandia just out for you...

Avandia is going to have similar recovery play as Crestor if not better, I suspect. Btw, Asia type 2 diabetes is now growing at an alarming rate. GSK will be able to take advantage on these markets with Andrew on the CEO role.

Pound took a turn at 2.11 last friday due to widening trade deficit. Suspect that's the peak. So, this share could be better than putting money in the bank.

Took a turn today after a few broker recommendations. Still cheap IMO.

Personally I think you won't see that much of a stronger dollar until 2009. FX markets always overrun too.

And this is what I call a great company! See below:

Glaxo to offer 2 mln stg packages, board seats to Viehbacher, Stout - report
AFX


LONDON (Thomson Financial) - Pharmaceutical giant GlaxoSmithKline is to offer 2 mln stg retention packages and seats on the board to Chris Viehbacher and David Stout, who missed out on becoming chief executive, an effort to keep them at the company, the Sunday Times reported without citing sources.

Viehbacher, who runs the group's US pharmaceuticals division, and David Stout, the president of pharmaceutical operations, missed out on the CEO's job when Andrew Witty was appointed to lead the group two months ago.

The group, the paper reported, has told investors that the share packages will be handed out to Viehbacher and Stout over the next two to three years. There will also be a small cash payment, the paper reported, without giving details.

alexander.ferguson@thomson.com

FDA Approves 19 New U.S. Drugs, Fewest Since '83; Glaxo Leads

By Justin Blum

Jan. 8 (Bloomberg) -- The U.S. Food and Drug Administration approved 19 new drugs in 2007, the fewest in 24 years, after drugmakers focused on developing uses for existing products.

"The hurdle has been raised, there is no question about it,'' said Jean-Pierre Garnier, Glaxo's chief executive officer, in an Oct. 24 conference call with analysts. ``We are working on 25 launches over the next three years. Some of them will be delayed that probably wouldn't have been delayed if we had those 25 products even two years ago.''

http://www.bloomberg.com/apps/news?pid=20601087&sid=a2MOCNVDHucs&refer=home

END of Report.

As to the bribery issue it appears that 2,200 companies from some 40 countries are suspected of colluding with Saddam's regime to bilk the humanitarian program of $1.8 billion.
Anyone who believes anything will come of any investigation with so many companies involved is IMHO living in dream land.
I would think the number of companies that went down the legal moral route are far less than those who didn't.

The bottom line is that to get any sort of deal with a corrupt country (and there are very few that are not) bribery is often a companies best bargaining chip. On a lesser scale if you want to deal with so called none corrupt countries it's called incentives, corruption by a lesser name.

The Authorities will make a lot of noise and spend a lot of our money, then everything will just fade away.
Cynicism rules.